| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Department of Obstetrics and Gynecology (S.Y., T.H., T.I., F.T., A.F., Y.S., N.Y., N.T.) and 2nd Department of Internal Medicine (G.S.), Tottori University School of Medicine, Yonago 683-8504, Japan
Address all correspondence and requests for reprints to: Souichi Yoshida, M.D., Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago 683-8504, Japan. E-mail: . souichi{at}grape.med.tottori-u.ac.jp
Abstract
Tumor progression is often regulated through interactions between carcinoma cells and host stromal cells. In this study of endometrial cancer, we investigated one mechanism potentially involved in hepatocyte growth factor (HGF)-mediated cancer-stromal interactions. Endometrial cancer cells (HEC-1 and ISHIKAWA) expressed the c-met receptor, but HGF did not. HGF, however, did stimulate the proliferation and invasion of these cells. The HGF gene was expressed in stromal cells, which had been separated from primary cultures of endometrial cancers, 6.4 times more than in isolated normal endometrial stromal cells. Immunohistochemical staining revealed immunoreactive HGF in cancer stromal cells, the staining intensity being more pronounced in cancer tissue than in normal endometrium. The conditioned medium from normal epithelial cells and cancer cell lines induced HGF production in normal stromal cells. We identified basic fibroblast growth factor as an HGF inducer derived from endometrial cancer cell lines. Basic fibroblast growth factor derived from tumor cells may induce HGF in endometrial stromal cells, whereas stromal cell-derived HGF leads to the invasive growth of carcinoma cells. These interactions, mediated by HGF and HGF inducers, may play a significant role in the progression of endometrial cancer.
This article has been cited by other articles:
![]() |
S. Battersby, K.J. Sales, A.R. Williams, R.A. Anderson, S. Gardner, and H.N. Jabbour Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway Hum. Reprod., January 1, 2007; 22(1): 36 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Jones, A. P. Houwink, B. K. Freeman, T. M. Greenwood, J. M. Lafky, W. L. Lingle, A. Berchuck, G. L. Maxwell, K. C. Podratz, and N. J. Maihle The Granulin-Epithelin Precursor Is a Steroid-Regulated Growth Factor in Endometrical Cancer Reproductive Sciences, May 1, 2006; 13(4): 304 - 311. [Abstract] [PDF] |
||||
![]() |
S. Yoshida, T. Harada, T. Iwabe, F. Taniguchi, M. Mitsunari, N. Yamauchi, I. Deura, S. Horie, and N. Terakawa A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis Hum. Reprod., August 1, 2004; 19(8): 1821 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yoshida, T. Harada, M. Mitsunari, T. Iwabe, Y. Sakamoto, S. Tsukihara, Y. Iba, S. Horie, and N. Terakawa Hepatocyte Growth Factor/Met System Promotes Endometrial and Endometriotic Stromal Cell Invasion via Autocrine and Paracrine Pathways J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 823 - 832. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |